<VariationArchive VariationID="10561" VariationName="NM_000133.4(F9):c.-17del" VariationType="Deletion" Accession="VCV000010561" Version="2" RecordType="classified" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2024-06-10" DateCreated="2013-04-04" MostRecentSubmission="2024-06-09">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="25600" VariationID="10561">
      <GeneList>
        <Gene Symbol="F9" FullName="coagulation factor IX" GeneID="2158" HGNC_ID="HGNC:3551" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>Xq27.1</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="X" Accession="NC_000023.11" start="139530739" stop="139563459" display_start="139530739" display_stop="139563459" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="X" Accession="NC_000023.10" start="138612894" stop="138645616" display_start="138612894" display_stop="138645616" Strand="+" />
          </Location>
          <OMIM>300746</OMIM>
          <Haploinsufficiency last_evaluated="2021-01-12" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=F9">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2021-01-12" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=F9">No evidence available</Triplosensitivity>
        </Gene>
      </GeneList>
      <Name>NM_000133.4(F9):c.-17del</Name>
      <CanonicalSPDI>NC_000023.11:139530746:AA:A</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>Xq27.1</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="X" Accession="NC_000023.11" start="139530747" stop="139530747" display_start="139530747" display_stop="139530747" variantLength="1" positionVCF="139530746" referenceAlleleVCF="CA" alternateAlleleVCF="C" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="X" Accession="NC_000023.10" start="138612906" stop="138612906" display_start="138612906" display_stop="138612906" variantLength="1" positionVCF="138612905" referenceAlleleVCF="CA" alternateAlleleVCF="C" />
      </Location>
      <OtherNameList>
        <Name>F9, 1-BP DEL, +13A</Name>
      </OtherNameList>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000023.10" sequenceAccession="NC_000023" sequenceVersion="10" change="g.138612907del" Assembly="GRCh37">
            <Expression>NC_000023.10:g.138612907del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000023.11" sequenceAccession="NC_000023" sequenceVersion="11" change="g.139530748del" Assembly="GRCh38">
            <Expression>NC_000023.11:g.139530748del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_007994.1" sequenceAccession="NG_007994" sequenceVersion="1" change="g.5013del">
            <Expression>NG_007994.1:g.5013del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000133.4" sequenceAccession="NM_000133" sequenceVersion="4" change="c.-17del" MANESelect="true">
            <Expression>NM_000133.4:c.-17del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001623" Type="5 prime UTR variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001313913.2" sequenceAccession="NM_001313913" sequenceVersion="2" change="c.-17del">
            <Expression>NM_001313913.2:c.-17del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001623" Type="5 prime UTR variant" DB="SO" />
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_556" sequenceAccession="LRG_556">
            <Expression>LRG_556:g.5013del</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="F9_000021" DB="LOVD 3" />
        <XRef Type="Allelic variant" ID="300746.0004" DB="OMIM" />
        <XRef Type="rs" ID="2148352878" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_000133.4(F9):c.-17del AND Hemophilia B leyden" Accession="RCV000011307" Version="3">
        <ClassifiedConditionList TraitSetID="2991">
          <ClassifiedCondition DB="MedGen" ID="CN043454">Hemophilia B leyden</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="1990-05-31" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="1990-05-31" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2013-04-04" MostRecentSubmission="2024-06-09">
        <ReviewStatus>no assertion criteria provided</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">2342576</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">2565449</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">2917196</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">3416069</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="2991" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="9345" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Hemophilia B leyden</ElementValue>
                <XRef ID="MONDO:0850054" DB="MONDO" />
              </Name>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="22455" />
                <XRef ID="22455" DB="Office of Rare Diseases" />
              </AttributeSet>
              <XRef ID="617930" DB="Orphanet" />
              <XRef ID="CN043454" DB="MedGen" />
              <XRef ID="MONDO:0850054" DB="MONDO" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="31535" SubmissionDate="2012-11-12" DateLastUpdated="2024-06-09" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="300746.0004_HEMOPHILIA B LEYDEN" title="F9, 1-BP DEL, +13A_HEMOPHILIA B LEYDEN" />
        <ClinVarAccession Accession="SCV000031535" DateUpdated="2024-06-09" DateCreated="2013-04-04" Type="SCV" Version="2" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="1990-05-31">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">Reitsma et al. (1989) studied the F9 gene in a Greek patient and an American patient of Armenian descent with hemophilia B Leyden (see 306900). In one they found deletion of A at position +13 of the factor IX gene and in the other an A-to-G mutation at the same position (300746.0090), 32 bp downstream of the point mutation in the Dutch kindred (Reitsma et al., 1988). See also Crossley et al. (1989). Crossley and Brownlee (1990) identified a binding site for the CCAAT/enhancer binding protein (C/EBP) extending from +1 to +18. They showed that the A-to-G mutation at +13 prevents the binding of C/EBP to this site. Furthermore, they showed that C/EBP is capable of transactivating a cotransfected normal factor IX promoter but not the mutant promoter.</Attribute>
              <Citation>
                <ID Source="PubMed">2917196</ID>
              </Citation>
              <Citation>
                <ID Source="PubMed">3416069</ID>
              </Citation>
              <Citation>
                <ID Source="PubMed">2565449</ID>
              </Citation>
              <Citation>
                <ID Source="PubMed">2342576</ID>
              </Citation>
              <XRef DB="OMIM" ID="306900" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="F9" />
          </GeneList>
          <Name>F9, 1-BP DEL, +13A</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">1-BP DEL, +13A</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="300746.0004" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">HEMOPHILIA B LEYDEN</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="31535" TraitType="Disease" MappingType="Name" MappingValue="HEMOPHILIA B LEYDEN" MappingRef="Preferred">
        <MedGen CUI="CN043454" Name="Hemophilia B leyden" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

